<?xml version="1.0" encoding="UTF-8"?>
<GaPExchange xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:noNamespaceSchemaLocation="./dbGaPEx2.1.5.xsd">

<MetaVariables>
	<Submitter/>
	<Method/>
</MetaVariables>
<MetaLinks/>

<Projects>
	<Project/>
</Projects>

<Studies>

<Study source="dbGaP" accession="phs000791.v1.p1" parentStudy="phs000791.v1.p1" createDate="2014-08-25" modDate="2014-08-28">

<Configuration>
	<Data_Provider><![CDATA[
		<table border="1">
		<tr><th>Title</th><th>Name</th><th>Institute</th></tr>
		<tr><td>Principal Investigator</td><td>Costello, Joseph, F. PhD</td><td>Department of Neurological Surgery, University California San Francisco, 			San Francisco, CA, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Hirst, Martin.  PhD</td><td>Canada&#39;s Michael Smith Genome Science Center, BC Cancer Agency, Department of Microbiology and Immunology, 			Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada</td></tr>
		<tr><td>Co-Investigator</td><td>Wang, Ting.  PhD</td><td>Washington University, Department of Genetics, St. Louis, MO, USA</td></tr>
		<tr><td>Co-Investigator</td><td>Marra, Marco, A. PhD</td><td>Canada&#39;s Michael Smith Genome Science Center, BC Cancer Agency, and Department of Medical Genetics, 			University of British Columbia, Vancouver, BC, Canada</td></tr>
		<tr><td>Co-Investigator</td><td>Farnham, Peggy J. PhD</td><td>Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern 			California, Los Angeles, CA, USA</td></tr>
		</table>
	]]></Data_Provider>
	<StudyNameEntrez>Integrated Epigenetic Maps of Human Embryonic, Extraembryonic and Adult Cells</StudyNameEntrez>
	<StudyNameReportPage>Integrated Epigenetic Maps of Human Embryonic, Extraembryonic and Adult Cells</StudyNameReportPage>
	<StudyTypes>
		<StudyType>Control Set</StudyType>
	</StudyTypes>
	<Description><![CDATA[
<p>Working cooperatively with other Mapping Centers and the Data Coordination Center (EDACC) funded by this Roadmap mechanism we have comprehensively mapped the epigenomes of select human cells with significant relevance to complex human disease. Our effort has been focused on cells relevant to human health and complex disease including cells from the blood, brain, breast, skin, male germ cells, extraembryonic tissues and trophoblast, and U.S. Government-approved lines of human embryonic stem cells. We have incorporated high quality, homogeneous cells from males and females, and two predominant racial groups, and biological replicates of each cell type. The resulting comprehensive maps include up to 6 histone modifications selected for their opposing roles in regulating active and inactive chromatin (H3K4me1, H3K4me3, H3K9me3, H3K9ac, H3K27ac, H3K27me3, H3K36me3), DNA methylation, miRNA and gene expression, and for select cases whole genome shotgun sequence. Our cell and data production pipeline incorporates verification and data validation with independent methods, and operates under a model motivated by increased data production and decrease cost. Our group in conjunction with the other REMC teams, the EDACC, ENCODE, Epigenetics of Human Health and Disease centers and the NIH Roadmap program are developing methods, tools and reference epigenome maps for the research community that will make the promise of epigenetics in understand and treating human complex disease a reality. Our reference epigenomes will enable new disciplines including human population epigenetics, comparative epigenomics, neuroepigenetics, and therapeutic epigenetics for tissue regeneration and reversal of disease.</p>]]>
	</Description>
	<StudyProjects>
		<Project/>
	</StudyProjects>
	<Publications>
		<Publication>
			<Pubmed pmid="20852635"/>
		</Publication>
		<Publication>
			<Pubmed pmid="20195257"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22127213"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22682255"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23255151"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23033340"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23629413"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23708189"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23804400"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23804401"/>
		</Publication>
		<Publication>
			<Pubmed pmid="23877302"/>
		</Publication>
		<Publication>
			<Pubmed pmid="24728854"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22960372"/>
		</Publication>
		<Publication>
			<Pubmed pmid="22495314"/>
		</Publication>
	</Publications>
	<Diseases>
		<Disease vocab_source="MESH" vocab_term="Neoplasms"/>
	</Diseases>
	<Attributions>
		<Header title="Principal Investigator">
			<AttName>Costello, Joseph, F. PhD</AttName>
			<Institution>Department of Neurological Surgery, University California San Francisco, 			San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Hirst, Martin.  PhD</AttName>
			<Institution>Canada&#39;s Michael Smith Genome Science Center, BC Cancer Agency, Department of Microbiology and Immunology, 			Centre for High-Throughput Biology, University of British Columbia, Vancouver, BC, Canada</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Wang, Ting.  PhD</AttName>
			<Institution>Washington University, Department of Genetics, St. Louis, MO, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Marra, Marco, A. PhD</AttName>
			<Institution>Canada&#39;s Michael Smith Genome Science Center, BC Cancer Agency, and Department of Medical Genetics, 			University of British Columbia, Vancouver, BC, Canada</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Farnham, Peggy J. PhD</AttName>
			<Institution>Department of Biochemistry and Molecular Biology, Norris Comprehensive Cancer Center, University of Southern 			California, Los Angeles, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Fisher, Susan. PhD</AttName>
			<Institution>Department of Cell and Tissue Biology, University California San Francisco, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Haussler, David. PhD</AttName>
			<Institution>Center for Biomolecular Science and Engineering,  University of California, Santa Cruz, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Jones, Steven JM.  PhD</AttName>
			<Institution>Canada&#39;s Michael Smith Genome Science Center, BC Cancer Agency, Canada</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>McManus, Michael.  PhD</AttName>
			<Institution>Department of Microbiology and Immunology, University California San Francisco, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Tlsty, Thea.  PhD</AttName>
			<Institution>Department of Neurological Surgery, Pathology and Microbiology and Immunology, University California San Francisco, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Co-Investigator">
			<AttName>Weiss, Arthur.  M.D. PhD</AttName>
			<Institution>Howard Hughes Medical Institute and Department of Rheumatology, University California San Francisco, San Francisco, CA, USA</Institution>
		</Header>
		<Header title="Funding Source">
			<AttName>5U01ES017154-02</AttName>
			<Institution>US National Institutes of Health (NIH) Roadmap Epigenomics Program, National Institutes of Health, MD, Bethesda, USA</Institution>
		</Header>
	</Attributions>
	<DisplayPublicSummary>yes</DisplayPublicSummary>
	<StudyURLs>
		<Url name="Roadmap Epigenomics Project" url="http://www.roadmapepigenomics.org/"/>
		<Url name="Roadmap Epigenomics Visualization Hub (VizHub)" url="http://vizhub.wustl.edu/"/>
		<Url name="Roadmap Epigenomics Browser" url="http://epigenomegateway.wustl.edu/"/>
		<Url name="Roadmap Epigenomics Visualization Hub at Wash U" url="http://genomebrowser.wustl.edu/"/>
	</StudyURLs>
	<StudyHistory><![CDATA[
<p>Biospecimens profiled within this project were derived from normal, disease-free adult and fetal tissues and cells.</p>]]>
	</StudyHistory>
	<ConsentGroups>
		<ConsentGroup groupNum="1" shortName="HMB" longName="Health/Medical/Biomedical"/>
	</ConsentGroups>
</Configuration>

  <AuthorizedAccess>
    <DacInfo ssDacId="0">
      <DacName>NIDA</DacName>
      <DacFullName>NIDA</DacFullName>
      <DacEmail>0</DacEmail>
      <DacPhone></DacPhone>
      <DacUrl></DacUrl>
    </DacInfo>
    <Policy Policy_ID="phs000791.v1.p1_policy" ref_ssDacId="0">
      <DisplayResearchStatement>yes</DisplayResearchStatement>
      <DisplayPublicSummary>yes</DisplayPublicSummary>
      <EmbargoLength>9</EmbargoLength>
      <YearsUntilRenewal>1</YearsUntilRenewal>
      <WeeksCancelRequest>8</WeeksCancelRequest>
      <PdfSupplementReqired>no</PdfSupplementReqired>
      <AcknowledgementText>
        <para>
          http://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000791.v1.p1
        </para>
      </AcknowledgementText>
      <DocumentSet>
        <DataUseCertificate Label="Data Use Certificate" FilePath="https://dbgap.ncbi.nlm.nih.gov/aa/wga.cgi?page=DUC&amp;view_pdf&amp;stacc=phs000791.v1.p1" FileName=""/>
      </DocumentSet>
    </Policy>
    <ConsentGroups>
      <ParticipantSet groupNum-REF="1">
        <ConsentName>Health/Medical/Biomedical</ConsentName>
        <ConsentAbbrev>HMB</ConsentAbbrev>
        <UseLimitation>Use of this data is limited to health/medical/biomedical purposes, does not include the study of population origins or ancestry.</UseLimitation>
        <IrbRequired>No</IrbRequired>
      </ParticipantSet>
    </ConsentGroups>
  </AuthorizedAccess>


</Study>

</Studies>

</GaPExchange>
